Sian Bigora - Aug 5, 2022 Form 4 Insider Report for Processa Pharmaceuticals, Inc. (PCSA)

Role
Chief Development Officer
Signature
/s/ Sian Bigora by Michael B. Kirwan, as Attorney-in-Fact
Stock symbol
PCSA
Transactions as of
Aug 5, 2022
Transactions value $
$0
Form type
4
Date filed
8/9/2022, 04:25 PM
Previous filing
Jul 5, 2022
Next filing
Oct 3, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PCSA Common Stock Options Exercise +7.6K +1.92% 403K Aug 5, 2022 Direct F1
holding PCSA Common Stock 133K Aug 5, 2022 By CorLyst, LLC
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Vesting of time-based restricted shares.